Rotterdam, Netherlands

Mirjam Van Der Burg

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mirjam Van Der Burg: Innovator in Immunodeficiency Diagnostics

Introduction

Mirjam Van Der Burg is a prominent inventor based in Rotterdam, Netherlands. She has made significant contributions to the field of immunology, particularly in the diagnosis of primary immunodeficiencies. With a total of 2 patents, her work has advanced the understanding and detection of these complex conditions.

Latest Patents

Her latest patents focus on reagents, methods, and kits for diagnosing primary immunodeficiencies (PID). These inventions specifically address the diagnosis of PID of the lymphoid system. The unique reagent compositions she developed are designed for flow cytometric immunophenotyping of leukocytes. These compositions include fluorochrome-conjugated antibodies that target various specific combinations of markers. Additionally, her patents provide kits that incorporate these reagent compositions and outline methods for their use.

Career Highlights

Mirjam Van Der Burg is affiliated with the Erasmus University Medical Center Rotterdam, where she continues her research and innovation in immunology. Her work has been instrumental in improving diagnostic techniques for primary immunodeficiencies, which can significantly impact patient care and treatment outcomes.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Jacobus Johannes Maria Van Dongen and José Alberto Orfao De Matos Correia E Vale. These collaborations have further enriched her research and contributed to the advancements in her field.

Conclusion

Mirjam Van Der Burg's contributions to the field of immunology through her innovative patents and collaborations highlight her role as a leading inventor in the diagnosis of primary immunodeficiencies. Her work continues to pave the way for improved diagnostic methods and better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…